Corbus Pharmaceuticals Reports Second Quarter Financial Results and Corporate Updates

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today reported…

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today reported financial results for the second quarter of 2020. The Company also provided clinical and corporate updates. “We had a busy second quarter as we prepare for a potentially transformative second […]

The post Corbus Pharmaceuticals Reports Second Quarter Financial Results and Corporate Updates appeared first on Technical420.

Leave a Reply

Your email address will not be published. Required fields are marked *